Full Printable Schedule-at-a-Glance


8:00 a.m.

Registration and Continental Breakfast

9:00 a.m.

Welcome and Opening Remarks

9:15 a.m.

Reducing Neonatal Intensive Care Unit (NICU) Admissions With Single-Embryo Transfer, Eric D. Levens, MD, FACOG, Shady Grove Fertility Reproductive Science Center

Assisted reproductive technologies have become an evermore commonly accepted medical treatment for infertility. However, many controversial areas exist in this practice, including determining the optimal number of embryos for transfer, in an effort to control the rising number of multiple gestations and the associated complications of multiple births. This speaker will review trends in NICU admissions as a result of assisted reproductive technologies, discuss barriers to reductions in multiple births, explain the role of in vitro fertilization (IVF) in reducing the risk of ovarian hyperstimulation and describe candidates for single-embryo transfer.

10:00 a.m.

Perinatal Strategies to Improve Neonatal Care, Ramasubbareddy Dhanireddy, MD, University of Tennessee Health Science Center

Despite great strides in improving prenatal care utilization among American women, key perinatal indicators have remained stagnant or worsened in the past decade, and the United States continues to rank near the bottom compared to other developed countries. Powerful influences on outcome occur long before pregnancy begins, and pregnancy outcome is shaped by social, psychological, behavioral, environmental, and biological factors. Approaches to prenatal health that simultaneously consider multiple determinants throughout a woman's entire life span may need to be adopted.

Interventions that help detect and treat health conditions, as well as modify behaviors and risk factors that contribute to adverse maternal and infant outcomes, are critical components of maternal health. This presentation will identify these interventions that, if implemented before pregnancy, can improve pregnancy outcomes for women and infants.

10:45 a.m.


11:00 a.m.

Early Identification of Congenital Heart Disease (CHD): Maximizing Outcomes, Gil Wernovsky, MD, The Children's Hospital of Philadelphia

Thousands of babies are born each year with cardiovascular defects. CHD is the most common fatal congenital anomaly in the first year after birth, and early diagnosis of CHD is needed to ensure these babies receive prompt intervention to maximize outcomes and limit morbidities. Fetal echocardiography has become accepted as a method of diagnosing CHD in utero. This presentation will discuss methods to identify mothers that should receive in utero screening diagnosis for CHD and will evaluate the benefits of prenatal diagnosis.


Diabetes and Pregnancy: Minimizing Risk for Mom and Baby, Kristin Atkins, MD, University of Maryland School of Medicine

Managing the medical care of pregnant women with preexisting diabetes presents clinicians with a broad spectrum of problems. Reducing the risk of serious maternal and fetal complications for this population is increasingly important and is impacted by achieving stable glucose levels before pregnancy. This session will focus on the effects of diabetes on pregnancy and neonates. Keys to managing the pregnant diabetic patient, including metabolic and glycemic control, to help maximize outcomes will also be discussed.

12:45 a.m.

LUNCHEON PRESENTATION-An Overview of OptumHealth Care Solutions (optional)

OptumHealth features best-in-class programs and services in case management, disease management, treatment of complex medical conditions, decision support, physical medicine, and wellness. Learn about the products and services available through OptumHealth that can help payers and employers aggressively manage costs while enhancing members'/employees' health and well-being.

2:00 p.m.

Pregnancy, Obesity, and Bariatric Surgery: Maternal, Fetal, and Infant Implications, Sayeed Ikramuddin, MD, University of Minnesota

With the rapidly increasing prevalence of obesity in the United States, obesity during pregnancy is now a common high-risk obstetrical condition and is associated with numerous maternal, fetal, and neonatal complications. The use of bariatric surgery has also increased among women of reproductive age. This presentation will address managing pregnancy in obese patients and explore how pregnancy management differs in those who have undergone bariatric surgery.

2:45 p.m.

The Impact of Cancer: Pregnancy and Infertility Issues, David P. Cohen, MD, University of Chicago  Medical Center

Cancer occurs in approximately one out of every 1,000 pregnancies according to the American Society of Clinical Oncology. Although cancer and pregnancy are not usually conditions that are associated with one another, treating a pregnant woman with cancer is a delicate balancing act that may raise potential conflicts between optimal maternal therapy and fetal well-being.

Fertility is an extremely important issue related to long-term quality of life for cancer survivors. Concerns about fertility are common as patients undergo life-saving cancer treatments that may result in infertility. Thought must be given to whether patients' fertility is likely to be impacted by their treatment. This discussion should ideally occur prior to the start of therapy when there may be time to preserve the patient's future reproductive potential.

This speaker will explore the impact that pregnancy has on cancer, as well as the effects on both mother and fetus of the malignant-disease process and its treatments. The discipline of fertility preservation, including options, timing, and patient education will also be discussed.

3:45 p.m.


4:00 p.m.

Cord Blood Stem Cell Usage: Current and Future Applications in this Field, Mary J.Laughlin, MD, University of Virginia Health System

Cord Blood Banking offers the opportunity to cryogenically preserve a newborn's umbilical cord blood stem cells, enabling parents to preserve these precious stem cells that are unique to the newborn, and genetically related to their families. Dozens of cancers and blood disorders are already being treated with cord blood stem cells and there are many developing applications of stem cell technologies, such as its use in treating heart disease, diabetes and cerebral palsy. This presentation will include developments in the use of cord blood as a source for transplantation and will include a current review of the outcomes and the future direction of this initiative.

4:45-5:30 p.m.

Parenting the Premature Infant: Enhancing Infant-Parent Relationships in the NICU, Nancy Feinstein, RNC, PhD, COPE for HOPE, Inc.

Parenting is a challenging process under ideal circumstances. Parents of preterm infants are faced with even greater challenges and increased stressors both in the NICU and postdischarge. This speaker will describe interventions to enhance parent-infant interactions to prevent adverse developmental outcomes, as well as explain the case manager's role in developing patients' awareness of resources available to parents of premature infants.

5:30-7:00 p.m.


Join your colleagues for hors d'oeuvres and beverages. You won't want to miss this opportunity to gather information and ideas from exhibitors regarding the management of complex medical conditions.

FRIDAY—MAY 13, 2011

7:30 a.m.

Continental Breakfast

8:00 a.m.

Hormone Replacement Therapy (HRT) for Menopausal Women-What's the Story? Cynthia A. Stuenkel, MD, University of California, San Diego

Peri- and postmenopausal women's health issues cover a wide range of diseases and conditions. The risk-benefit ratio for hormone therapy for both disease prevention and treatment of specific menopause-related symptoms remain up for debate. This session will outline the importance of patient-specific treatment goals in determining hormone therapy regimens. Recent research findings from the Women's Health Initiative and other studies that offer important information about the risks and benefits of long-term menopausal hormone therapy will also be addressed.

9:00 a.m.

Postpartum Depressive Disorders, Mary Kenny, RN, MS, and Aparna Sharma, MD, Loyola University Medical Center

Postpartum depression may be one of the most under-recognized and under-treated disorders, and yet it impacts the lives of hundreds of thousands of new mothers. Women with postpartum depression have a 50 percent chance of getting it after subsequent pregnancies and may be at an increased risk for future depression not associated with pregnancy (source: NIH's National Institute of Mental Health). During the postpartum period, up to 85 percent of women experience some type of mood disturbance. For most women, symptoms are transient and relatively mild; however, 10-15 percent of women experience a more disabling and persistent form of depression and 0.1-0.2 percent of women experience postpartum psychosis.

Untreated postpartum depression can place both the mother and infant at risk and is associated with significant long-term effects on child development and behavior. Although treatment options are available, both patients and their caregivers frequently overlook postpartum depression.This presentation will discuss appropriate screening, the importance of prompt recognition, and nonpharmacologic and pharmacologic options to treat depression, and how these are essential for both maternal and infant well-being.

10:00 a.m.


10:15 a.m.

Women and Migraine, Robert G. Kaniecki, MD, University of Pittsburgh School of Medicine

Migraine is a neurologic disorder characterized by a cycle of attacks, including sever headaches, separated by attack-free periods. Migraine-associated disability is substantial and pervasive and migraine headaches can cause debilitating pain resulting in days missed from work or school and overall decreased quality of life. The number of migraine sufferers continues to increase considerably commensurate with the growth of the population and migraine is an important target for public health interventions because it is highly prevalent and disabling.

Of all types of migraines, those associated with menstruation tend to be the longest-lasting, most severe, and most confusing and difficult to treat-up to 60 percent of all women suffering from migraines are affected by these potentially disabling headaches. The high numbers of migraines among women occurring at times of great hormonal fluctuation indicates a connection between migraine headache pain and female hormones.

This presentation will differentiate among the various types of migraine, identify pharmacologic and behavioral options for acute and prophylactic management of migraine and discuss when hormonal medication is a safe and helpful option for women with migraines.

11:00 a.m.

High-Risk Maternity Management, Mahmoud A. Ismail, MD, University of Chicago Medical Center

More than half a million babies are born preterm each year. Preterm birth, or birth before 37 weeks of pregnancy, is a serious health problem that costs the United States more than $26 billion annually. It is the leading cause of newborn death, and babies who survive often face the risk of lifetime health challenges, including learning disabilities, cerebral palsy, and intellectual disabilities (source: March of Dimes). Even infants born just a few weeks too soon have a greater risk of respiratory distress syndrome, feeding difficulties, hypothermia, jaundice and delayed brain development.

In addition, elective labor induction in women who have had a previous birth is common, but choosing when to induce is an area of obstetrical debate since adverse neonatal outcomes have been associated with inductions prior to 39 weeks gestation.

This presentation will review how early detection of risk factors helps reduce the incidence and severity of preterm birth through preconception coaching, prenatal management and education, and proactive management of pregnancies considered high risk for preterm birth. Management of premature rupture of membranes as well as the debate on timing of inductions will also be discussed.


Lunch (provided)

1:00 p.m.

Diagnosis and Management of Ovarian Cancer, Julian C. Schink, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Ovarian cancer is the fifth leading cause of cancer deaths in women. Because symptoms often do not occur until late in the disease, only about 20 percent of ovarian cancers are found at an early stage, while there is the greatest chance that it can be treated with success. There is no definitive screening test for early diagnosis of ovarian cancer, and choosing the optimal therapeutic intervention at the earliest possible stage is critical to extending progression-free survival in ovarian cancer patients. This presentation will provide an update on screening, diagnosing, treating and preventing ovarian cancer.

2:00 p.m.

Optimal Therapy for Breast Cancer: Standards and New Approaches, Tufia Haddad, MD, University of Minnesota

According to the American Cancer Society, breast cancer claimed an estimated 39,840 lives (women) in the United States last year. Despite huge strides during the past 20 years in the diagnosis and management of breast cancer, its incidence and mortality rate remain high. Breast cancer is commonly treated by various combinations of surgery, radiation therapy, chemotherapy and hormone therapy. Prognosis and selection of therapy may be influenced by several clinical and pathology features. This presenter will review factors that are used to determine the treatment plan for patients with recurrent, advanced or metastatic breast cancer.

3:00 p.m.


Note: OptumHealth Education reserves the right to make any necessary changes to this program. Efforts will be made to keep presentations as scheduled. Unforeseen circumstances may result in the substitution of faculty or content. Check the hotel reader boards to confirm room assignments.

Updated 3/15/2011